Annual report pursuant to Section 13 and 15(d)

Shareholders??? Equity (Details Narrative)

Shareholders’ Equity (Details Narrative)								3 Months Ended		9 Months Ended	12 Months Ended
Shareholders’ Equity (Details Narrative)	Dec. 29, 2020 USD ($) $ / shares shares	Nov. 24, 2020 USD ($) $ / shares shares	May 10, 2020 USD ($) Investors	May 01, 2020 shares	Nov. 08, 2017 USD ($) Investors $ / shares shares	Jul. 25, 2017 USD ($)	May 10, 2017 USD ($) shares	Mar. 31, 2021 USD ($) shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares	Mar. 15, 2021 USD ($)	Jan. 28, 2021 shares
Subsidiary, Sale of Stock [Line Items]
Stock issued during the period exercised											756,540
Gross proceeds from common stock \| $											$ 26,676,392	$ 11,339,375
Gross proceeds from exercise of warrants \| $											2,261,337	5,182,403
Gross proceeds from stock option exercised \| $											$ 363,139
Preferred stock, shares authorized											50,000,000	50,000,000
Series A Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of preferred stock converted							2,583,000
Number of shares issued upon conversion, convertible preferred stock							258,300
Warrants description							The warrants have a term of seven years from the date of issuance are non-exercisable until 6 months after issuance, have an exercise price of $3.10 per share
Series A Convertible Preferred Stock [Member] \| First Closing [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase							462,106
Gross proceeds \| $							$ 1,302,000
Series A Convertible Preferred Stock [Member] \| Second Closing [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase							602,414
Gross proceeds \| $						$ 1,698,000
Series A Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized							12,000,000
Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized											6,600,000
Series C Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Redemption of preferred shares														26.697
Redemption of preferred stock \| $													$ 5,600,000
Three Accredited Investors [Member] \| Securities Purchase Agreement [Member] \| Series A Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of accredited investors \| Investors			3
Proceeds from convertible preferred stock \| $			$ 3,000,000
Description on preferred stock, conversion basis							The full $3,000,000 of Preferred Stock, and after giving effect to the reverse stock split and the previous conversion of 2,583,000 shares of Series A Preferred Stock into 258,300 shares of the Company’s common stock, is convertible into nine hundred, forty-one thousand, seven hundred and one shares of our common stock, based on a fixed conversion price of $2.50 per share on an as-converted basis
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued during the period								2,472,573		756,540
Stock issued during the period exercised											756,540	5,680,114
Gross proceeds from common stock \| $								$ 27,800,000
Gross proceeds from exercise of warrants \| $								$ 2,300,000
Gross proceeds from stock option exercised \| $										$ 363,139
Common Stock [Member] \| ATM Program [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued during the period								21,398,765
2018 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued during the period									5,642,114
Warrants to purchase									4,294,500
Number of shares issued for warrants									760,000
Warrants exercise price per share \| $ / shares									$ 1.00
2019 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase									9,583,334
Number of shares issued for warrants									4,882,114
Warrants exercise price per share \| $ / shares									$ 0.90
2018 Warrants and 2019 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Gross proceeds from exercise of warrants \| $									$ 5,153,902
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase								2,472,573
November 2020 Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from public offering \| $		$ 6,000,000.0
November 2020 Public Offering [Member] \| Dr. Frederick Telling [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase		100,000
November 2020 Public Offering [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued during the period		14,189,189
Share price per unit \| $ / shares		$ 0.37
Stock issued during the period exercised		2,128,378
November 2020 Public Offering [Member] \| Common Stock [Member] \| Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares of stock available for purchase		2,128,378
December 2020 Registered Direct Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from public offering \| $	$ 6,500,000
December 2020 Registered Direct Offering [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued during the period	14,444,444
Share price per unit \| $ / shares	$ 0.45
Private Placement [Member] \| Series B Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of accredited investors \| Investors					4
Description on preferred stock, conversion basis					The full $3,300,000 of Series B Convertible Preferred Stock is convertible, after giving effect to the reverse stock split into one million three hundred and twenty thousand and two shares of our Common Stock, based on a conversion of one share of Series B Preferred Stock into two shares of Common Stock. The purchase price per share of the Series B Preferred Stock is represented by $2.50 per share of the Common Stock on an as converted basis
Proceeds from issuance of private placement \| $					$ 3,300,000
Private Placement [Member] \| Warrant [Member] \| Series B Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase					1,064,518
Warrants exercise price per share \| $ / shares					$ 3.10
Term of warrants					7 years
Noachis Terra Inc. [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued during the period				9,200,000